Abstract
The basic strategy being proposed is one of studying the time-course of antipsychotic drug effects upon performance measures in parallel with the timecourse of drug effects upon the symptoms of schizophrenia, general morbidity and ward behavior. Critical for the productivity of this strategy is the inclusion of performance measures that reflect functioning in psychological processes—e.g., attention, perception etc., in which schizophrenic-specific deficit or deviance has been demonstrated and which may be presumed to mediate symptom formation. Promising candidates for inclusion in a battery of performance measures under these criteria are those reflecting functioning in the information-processing sequence, i. e., in sensory-attentional-perceptual-cognitive processes. Given this approach, the examination of relationships between patterns of change at the level of deficit performance and of symptomatology, has the potentiality of disclosing both mechanisms of drug action and critical mediating mechanisms of schizophrenic disorder.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.